血细胞膜伪装益生菌驱动的微型机器人用于双靶向血栓治疗
Blood Cell Membrane Camouflaged Probiotic-Powered Micro-robot for Dual-Targeted Thrombus Therapy
Riyue Liu, Kexin Zhang, Jiale Chen, Nawsherwan, Jinrong Zheng, Yan Wang, Mangmang Sang
Journal:Materials Today Bio
IF:11
DOI:10.1016/j.mtbio.2026.103428
PMID:
Published:2026-07-03
research field:药物递送系统微机器人技术生物医学工程血栓与止血纳米医学
Abstract
Conventional thrombolytic agents exhibit significant limitations in treating thrombotic disorders characterized by narrow therapeutic windows and persistent vascular injury, failing to meet clinical requirements in terms of precision, timeliness, and treatment durability. To address these challenges, we have developed a blood cell membrane-camouflaged probiotic-powered micro-robot system (EcN-PN/rt-PA). This innovative system utilizes natural probiotics as biological carriers functionalized with drug-loaded hybrid membrane nanovesicles possessing dual-targeting capabilities against thrombus. By harnessing the rapid motility of probiotics and the active targeting properties of the hybrid membranes, the system achieves rapid and precise delivery of thrombolytic drugs to thrombotic tissues. Capitalizing on the innate rod-shaped structure and self-propelling capacity of probiotics, this micro-robot demonstrates enhanced penetration depth into thrombotic tissues, significantly improving thrombolytic efficiency. Experimental results reveal that this thrombolytic micro-robot, which combines thrombus targeting, deep penetration, and prolonged circulation characteristics, not only rapidly and accurately targets and penetrates thrombotic tissues but also extends the biological half-life of thrombolytic drugs approximately 193-fold, enabling sustained thrombolytic effects while effectively inhibiting secondary thrombus formation. This novel dual-targeting thrombolytic strategy provides an important scientific solution for treating thrombotic diseases with narrow therapeutic windows caused by vascular injury.
本文使用的Yeasen产品
南美超级胎牛血清999尝鲜特惠


